Quarterly Transactions Made in Verve Therapeutics, Inc. (VERV)
This table provides information about the institutional ownership of Verve Therapeutics, Inc. (VERV). The information is specifically focused on institutions that hold shares of Verve Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 3,348,671 | 2,012,636 | 5,361,307 | 1,110,034 | 1,511,642 | 2,621,676 | 2,739,631 | |
| Q4 2021 | 4,777,796 | 3,530,325 | 8,308,121 | 1,788,050 | 83,919 | 1,871,969 | 6,436,152 | |
| Q1 2022 | 5,127,732 | 774,635 | 5,902,367 | 3,831,945 | 978,437 | 4,810,382 | 1,091,985 | |
| Q2 2022 | 2,594,904 | 1,086,435 | 3,681,339 | 4,030,997 | 1,617,306 | 5,648,303 | -1,966,964 | |
| Q3 2022 | 13,333,737 | 6,044,327 | 19,378,064 | 2,596,315 | 114,117 | 2,710,432 | 16,667,632 | |
| Q4 2022 | 7,213,663 | 1,140,184 | 8,353,847 | 4,156,886 | 0 | 4,156,886 | 4,196,961 | |
| Q1 2023 | 3,650,564 | 553,093 | 4,203,657 | 2,520,215 | 4,000 | 2,524,215 | 1,679,442 | |
| Q2 2023 | 3,526,157 | 177,466 | 3,703,623 | 3,644,444 | 0 | 3,644,444 | 59,179 | |
| Q3 2023 | 3,701,846 | 763,728 | 4,465,574 | 1,886,543 | 0 | 1,886,543 | 2,579,031 | |
| Q4 2023 | 11,385,898 | 5,787,606 | 17,173,504 | 4,282,809 | 0 | 4,282,809 | 12,890,695 | |
| Q1 2024 | 9,862,631 | 1,516,772 | 11,379,403 | 2,898,785 | 0 | 2,898,785 | 8,480,618 | |
| Q2 2024 | 8,834,329 | 2,915,751 | 11,750,080 | 15,937,608 | 0 | 15,937,608 | -4,187,528 | |
| Q3 2024 | 6,619,861 | 4,288,730 | 10,908,591 | 5,921,417 | 2,936,063 | 8,857,480 | 2,051,111 | |